Drug intelligence / Profile preview

BAY 987519

Development stage: Phase 1
Lead developer: Bayer
Administration: Transdermal, Topical

Overview

**BAY 987519** is a Bayer-sponsored topical sunscreen product evaluated in completed human studies of sun protection factor and UVA protection factor, including static, water-resistant, and supervised outdoor-use assessments in sport users. Public trial records identify it as an SPF 50 sunscreen spray product, but do not disclose its individual ultraviolet-filter active ingredients, detailed formulation, or a marketed trade name. ([deltatrials.com](https://deltatrials.com/trial/NCT02857478))

Beyond the preview

Go deeper on BAY 987519.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BAY 987519.

Explore the full profile